Anti-BLNK/ AGM4/ BASH-S monoclonal antibody

Anti-BLNK/ AGM4/ BASH-S antibody for FACS & in-vivo assay

Target products collectionGo to BLNK/BLNK products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2024-Ab-1/ GM-Tg-hg-MP2024-Ab-2Anti-Human BLNK monoclonal antibodyHuman
GM-Tg-rg-MP2024-Ab-1/ GM-Tg-rg-MP2024-Ab-2Anti-Rat BLNK monoclonal antibodyRat
GM-Tg-mg-MP2024-Ab-1/ GM-Tg-mg-MP2024-Ab-2Anti-Mouse BLNK monoclonal antibodyMouse
GM-Tg-cynog-MP2024-Ab-1/ GM-Tg-cynog-MP2024-Ab-2Anti-Cynomolgus/ Rhesus macaque BLNK monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2024-Ab-1/ GM-Tg-felg-MP2024-Ab-2Anti-Feline BLNK monoclonal antibodyFeline
GM-Tg-cang-MP2024-Ab-1/ GM-Tg-cang-MP2024-Ab-2Anti-Canine BLNK monoclonal antibodyCanine
GM-Tg-bovg-MP2024-Ab-1/ GM-Tg-bovg-MP2024-Ab-2Anti-Bovine BLNK monoclonal antibodyBovine
GM-Tg-equg-MP2024-Ab-1/ GM-Tg-equg-MP2024-Ab-2Anti-Equine BLNK monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2024-Ab-1/ GM-Tg-hg-MP2024-Ab-2; GM-Tg-rg-MP2024-Ab-1/ GM-Tg-rg-MP2024-Ab-2;
GM-Tg-mg-MP2024-Ab-1/ GM-Tg-mg-MP2024-Ab-2; GM-Tg-cynog-MP2024-Ab-1/ GM-Tg-cynog-MP2024-Ab-2;
GM-Tg-felg-MP2024-Ab-1/ GM-Tg-felg-MP2024-Ab-2; GM-Tg-cang-MP2024-Ab-1/ GM-Tg-cang-MP2024-Ab-2;
GM-Tg-bovg-MP2024-Ab-1/ GM-Tg-bovg-MP2024-Ab-2; GM-Tg-equg-MP2024-Ab-1/ GM-Tg-equg-MP2024-Ab-2
Products NameAnti-BLNK monoclonal antibody
Formatmab
Target NameBLNK
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-BLNK benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species BLNK/ AGM4/ BASH-S VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2024
    Target NameBLNK
    Gene ID29760,17060,499356,704363,486814,101086423,510393,100070841
    Gene Symbol and SynonymsAGM4,BASH,bca,BLNK,BLNK-S,Ly-57,LY57,Lyw-57,SLP-65,SLP65
    Uniprot AccessionQ8WV28,Q4KM52
    Uniprot Entry NameBLNK_HUMAN,BLNK_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000095585
    Target ClassificationTumor-associated antigen (TAA)

    The target: BLNK, gene name: BLNK, also named as AGM4, BASH-S, LY57, SLP-65, SLP65, bca, BLNK. This gene encodes a cytoplasmic linker or adaptor protein that plays a critical role in B cell development. This protein bridges B cell receptor-associated kinase activation with downstream signaling pathways, thereby affecting various biological functions. The phosphorylation of five tyrosine residues is necessary for this protein to nucleate distinct signaling effectors following B cell receptor activation. Mutations in this gene cause hypoglobulinemia and absent B cells, a disease in which the pro- to pre-B-cell transition is developmentally blocked. Deficiency in this protein has also been shown in some cases of pre-B acute lymphoblastic leukemia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, May 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.